Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer

Completed · Phase 3

Conditions studied: Breast Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether paclitaxel is more effective than docetaxel for breast cancer. PURPOSE: Randomized phase III trial to study the effectiveness of paclitaxel or docetaxel in treating women with stage IIIB or metastatic breast cancer.

Key facts

Study ID

NCT00002662

Run by

Aventis Pharmaceuticals

Starts

1994-08-01

Expected to finish

2004-06-01

Last updated by the study team

2013-08-02

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Montclair Regional Cancer Center — Birmingham, Alabama, United States
• Highlands Oncology Group, P.A. - Fayetteville — Fayetteville, Arkansas, United States
• Northeast Arkansas Clinic — Jonesboro, Arkansas, United States
• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
• California Cancer Care, Inc. — Greenbrae, California, United States
• Green Cancer Center at Scripps Clinic — La Jolla, California, United States
• Sidney Kimmel Cancer Center — San Diego, California, United States
• University of Colorado Cancer Center at University of Colorado Health Sciences Center — Denver, Colorado, United States
• Norwich Cancer Center — Norwich, Connecticut, United States
• George Washington University Medical Center — Washington D.C., District of Columbia, United States
• Baptist Regional Cancer Institute - Jacksonville — Jacksonville, Florida, United States
• Georgia Cancer Specialists - DeKalb — Decatur, Georgia, United States
• Rush-Presbyterian-St. Luke's Medical Center — Chicago, Illinois, United States
• James Graham Brown Cancer Center at University of Louisville — Louisville, Kentucky, United States
• Maine Center for Cancer Medicine and Blood Disorders - Scarborough — Scarborough, Maine, United States
• Tufts - New England Medical Center — Boston, Massachusetts, United States
• University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
• Southfield Oncology Institute, Inc. — Southfield, Michigan, United States
• Mercy Arch Hematology Oncology, P.C. — St Louis, Missouri, United States
• Carolinas Hematology-Oncology Associates — Charlotte, North Carolina, United States
• Blumenthal Cancer Center at Carolinas Medical Center — Charlotte, North Carolina, United States
• Charles M. Barrett Cancer Center at University Hospital — Cincinnati, Ohio, United States
• Cleveland Clinic Taussig Cancer Center — Cleveland, Ohio, United States
• Hematology Oncology Consultants Inc — Columbus, Ohio, United States
• Penn State Cancer Institute at Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.